Injective Surges on SEC Transfer Agent Registration and RWA Narrative
Injective's institutional arm has become an SEC-registered transfer agent, a significant milestone that positions Injective as a compliant venue for tokenized institutional funds and real-world assets. This news drove an approximately 8% increase in INJ trading, with the market cap nearing $450 million.
The SEC transfer agent status is part of a broader RWA and tokenization narrative for Injective. The company now supports four live tokenized asset classes: institutional funds, public equities, private company shares, and enterprise receivables. POSCO International and LG CNS have selected Injective for pilots that tokenize trade receivables from real international commerce.
Social traders on X have directly linked the SEC transfer agent news to the price strength, with one post noting it as a clear catalyst. Influential accounts are framing INJ as an RWA and tokenization play, pointing to regulatory rails, institutional infrastructure, and onchain finance as the real story behind the recent price move.